Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Omori

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|April 14, 2025
Roles of MASP-1 and MASP-3 in the development of retinal degeneration in a murine model of dry age-related macular degenerationTomoko Omori, Takeshi Machida, Yumi Ishida, et al.
Frontiers in Immunology|September 2, 2022
The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulationKohei Kusakari, Takeshi Machida, Yumi Ishida, et al.
BMC Research Notes|January 25, 2013
An adult patient with Henoch-Schönlein purpura and non-occlusive mesenteric ischemiaChiyako Oshikata, Naomi Tsurikisawa, Masakazu Takigawa, et al.
BMC Ophthalmology|July 18, 2023
Tear fluid and complement activation products in tears after ocular surgeryHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
Experimental Eye Research|April 1, 2020
Anaphylatoxin concentration in aqueous and vitreous humor in the eyes with vitreoretinal interface abnormalitiesYasuharu Oguchi, Tetsuju Sekiryu, Tomoko Omori, et al.
Scientific Reports|January 3, 2024
Complement activation products in tears of dry eye and meibomian gland dysfunctionHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2020
A novel complement inhibitor sMAP-FH targeting both the lectin and alternative complement pathwaysMika Takasumi, Tomoko Omori, Takeshi Machida, et al.
Ophthalmology Science|October 17, 2022
Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular DegenerationYutaka Kato, Yasuharu Oguchi, Tomoko Omori, et al.
Japanese Journal of Ophthalmology|February 12, 2025
HTRA1 and complement activation in neovascular age-related macular degenerationKeiichiro Tanaka, Tomoko Omori, Yasuharu Oguchi, et al.
Investigative Ophthalmology & Visual Science|November 30, 2020
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular DegenerationYutaka Kato, Yasuharu Oguchi, Tomoko Omori, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|April 14, 2025
Roles of MASP-1 and MASP-3 in the development of retinal degeneration in a murine model of dry age-related macular degenerationTomoko Omori, Takeshi Machida, Yumi Ishida, et al.
Frontiers in Immunology|September 2, 2022
The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulationKohei Kusakari, Takeshi Machida, Yumi Ishida, et al.
BMC Research Notes|January 25, 2013
An adult patient with Henoch-Schönlein purpura and non-occlusive mesenteric ischemiaChiyako Oshikata, Naomi Tsurikisawa, Masakazu Takigawa, et al.
BMC Ophthalmology|July 18, 2023
Tear fluid and complement activation products in tears after ocular surgeryHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
Experimental Eye Research|April 1, 2020
Anaphylatoxin concentration in aqueous and vitreous humor in the eyes with vitreoretinal interface abnormalitiesYasuharu Oguchi, Tetsuju Sekiryu, Tomoko Omori, et al.
Scientific Reports|January 3, 2024
Complement activation products in tears of dry eye and meibomian gland dysfunctionHiroki Maehara, Koki Norikawa, Keiichiro Tanaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2020
A novel complement inhibitor sMAP-FH targeting both the lectin and alternative complement pathwaysMika Takasumi, Tomoko Omori, Takeshi Machida, et al.
Ophthalmology Science|October 17, 2022
Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular DegenerationYutaka Kato, Yasuharu Oguchi, Tomoko Omori, et al.
Japanese Journal of Ophthalmology|February 12, 2025
HTRA1 and complement activation in neovascular age-related macular degenerationKeiichiro Tanaka, Tomoko Omori, Yasuharu Oguchi, et al.
Investigative Ophthalmology & Visual Science|November 30, 2020
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular DegenerationYutaka Kato, Yasuharu Oguchi, Tomoko Omori, et al.
Pageof 2